When a patient complains of a “sore that won’t heal” or mentions that a lesion “constantly bleeds and scabs,” heed the advice of Osler.
When a patient complains of a "sore that won't heal" or mentions that a lesion "constantly bleeds and scabs," heed the advice of Osler: "Listen to the patient, he is telling you the diagnosis." This characteristic description best fits the diagnosis of a basal cell carcinoma.
Lebrikizumab Demonstrates Efficacy, Safety in Patients With Skin of Color With AD
June 11th 2025RAD 2025. Lebrikizumab improved skin clearance, itch, and pigmentation in patients with skin of color and atopic dermatitis, with strong safety data through 24 weeks, according to late-breaking data.